As a promising class of anti-cancer targets, HDAC involves in regulating expression of a ground amount of genes including pro-apoptotic genes, the epithelial marker E-cadherin, genes promoting neoplastic cell or cell differentiation and those involved in DNA damage responses, thus showing synergistic cytotoxicity with several targeted therapies including EGFR [30]. The gene discussed is CDH1; the disease is cancer.